Prime Medicine Inc (PRME)

R&D Expense Growth

-2.08%

Quarterly · Period ending:

PRME logo

PRME R&D Expense Growth

Latest reported-2.08%
PRME Quarterly R&D Growth (QoQ) (0.00% → -2.08%)
High-resolution chart · PNG

PRME r&d expense growth history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Prime Medicine Inc R&D Expense Growth — Quarterly
Period endingR&D Expense Growth
-2.0759%
-1.7402%
-21.098%
6.3202%
2.0043%
18.9362%
-15.4586%
-6.3407%
14.0229%
-8.8883%
1.201%
18.4052%
12.0434%
6.2592%
16.0259%
32.2439%
38.4807%
-74.1402%
614.7162%
29.9385%
24.7262%
262.6688%
0%
0%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.